Arbutus Biopharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 19, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	697	599	379	341	463	246
Market Cap Growth	6.75%	57.80%	11.19%	-26.27%	87.77%	60.15%
Enterprise Value	621	479	257	177	489	288
Last Close Price	3.54	3.03	2.27	2.12	3.23	2.90
PS Ratio	55.99	100.41	23.11	9.34	47.89	43.60
PB Ratio	10.57	6.36	3.95	2.66	3.11	2.96
P/TBV Ratio	10.57	6.36	3.95	2.66	3.11	-
EV/Sales Ratio	50.13	80.32	15.69	4.85	50.59	51.00
Debt / Equity Ratio	0.06	0.06	0.08	0.09	0.11	0.22
Net Debt / Equity Ratio	-1.15	-1.20	-1.17	-1.25	-1.02	-0.99
Net Debt / EBITDA Ratio	2.91	1.70	1.61	2.78	2.46	1.82
Net Debt / FCF Ratio	1.96	1.79	1.42	4.79	2.52	1.95
Asset Turnover	0.12	0.05	0.11	0.20	0.06	0.06
Quick Ratio	18.31	8.03	5.71	4.51	13.92	13.06
Current Ratio	18.80	8.15	5.87	4.60	14.32	13.39
Return on Equity (ROE)	-45.88%	-68.76%	-59.99%	-45.35%	-56.19%	-72.97%
Return on Assets (ROA)	-16.46%	-31.68%	-28.70%	-19.76%	-26.22%	-29.51%
Return on Capital Employed (ROCE)	-33.90%	-60.30%	-64.00%	-38.90%	-37.10%	-44.90%
Earnings Yield	-5.17%	-11.28%	-17.38%	-19.05%	-14.49%	-21.15%
FCF Yield	-5.55%	-10.50%	-20.74%	-9.84%	-12.99%	-17.14%
Buyback Yield / Dilution	-5.88%	-11.84%	-9.95%	-42.07%	-40.10%	-32.83%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.